Study Results Demonstrate that Pathwork® Tissue of Origin Test Impacts Diagnosis and Treatment

2011-11-29T22:59:07+00:00

CHANGE IN DIAGNOSIS
In a study with 111 patients, the Tissue of Origin Test was shown to impact the diagnosis:

Hornberger et al: Effect of a gene expressino-based Tissue of Origin Test on patient management for difficult-to diagnose primary cancers, poster presented at ASCO GI January 2011. San Francisco, CA
Data on file. Pathwork Diagnostics

CHANGE IN TREATMENT
The study also showed how knowing the diagnosis changed patient therapy:

Hornberger et al: Effect of a gene expressino-based Tissue of Origin Test on patient management for difficult-to-diagnose primary cancers, poster presented at ASCO GI January 2011. San Francisco, CA
Data on file. Pathwork Diagnostics

SURVIVAL OUTCOME
The study authors collected survival data on 107 of the original 111 patients, and the data show that patients who were diagnosed with the help of the Tissue of Origin Test have a median survival of 426 days:

Van de Wouw (2002), Greco, Erlander et al 2000 Greco Burris et al 2002
Greco, Rodriguiz et al 2004. Data on File. Pathwork Diagnostics

The Tissue of Origin Test is the ONLY Medicare-approved test of it's kind to provide evidence of improved patient outcomes.

Welcome to the Pathwork Diagnostics Blog

2011-11-16T19:45:43+00:00

Welcome to the Pathwork Diagnostics blog!

Our aim for this blog is to keep you informed of internal developments at Pathwork as well as to help you stay up-to-date on industry news and events within the medical community. We hope to create and maintain an open dialogue between Pathwork and the public as we work towards our goal of developing tools that provide better patient care.

Contributing to the blog will be Dr. Meredith Halks Miller, MD, Medical Laboratory Director and William David Henner, MD., Ph.D. Chief Medical Officer at Pathwork Diagnostics. Dr. Miller is Board Certified in both Anatomic and Neuropathology and has 30 years of experience as an experimental pathologist in academic, research, and global biopharma and biotechnology settings. Dr. Henner brings 25 years of significant scientific, clinical, and industry experience to Pathwork Diagnostics, providing clinical and medical leadership for the company’s clinical product development, thought leader collaborations and clinical study design.

We are excited about our venture into the blog world and look forward to reading your comments in the coming weeks!